#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Porphyria non-acute Congenital growth hormone deficiency Hormone-dependent prostate cancer Fibrodysplasia ossificans progressiva Immunodeficiency common variable Fibrosarcoma metastatic B-cell small lymphocytic lymphoma Non-renal cell carcinoma of kidney Langerhans' cell histiocytosis Chronic graft versus host disease in intestine Acquired haemophilia Bile acid synthesis disorder Leiomyosarcoma recurrent Raynaud's phenomenon Hepatocellular carcinoma More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Treatment Lennox-Gastaut syndrome – Diagnostics Mast cell activation syndrome – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Tuberous sclerosis complex – Treatment Lymphatic malformation – Trials in Disease Leukoencephalopathy – Basic Information Mucous membrane pemphigoid Von Willebrand’s disease – Life with Disease Pulmonary sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levamlodipine Succinate Sonidegib Aripiprazole Bms-986442 Ltp001 Aflibercept Olodaterol Promethazine Hydrochloride 7-Ethyl-10-Hydroxycamptothecin Bleomycin Meglumine Gadoterate Vafidemstat Meropenem Anhydrous ACETYLCARNITINE HYDROCHLORIDE Mirabegron Ro7589655 Phenobarbital Cefuroxime Namilumab Norucholic Acid More therapies…

    Learn about Your Condition

    Brain neoplasm Rectosigmoid cancer Adrenocortical carcinoma Ovarian epithelial cancer Neuroblastoma recurrent Right ventricular dysfunction Prostate cancer metastatic Post procedural infection Malabsorption Notalgia paraesthetica Perineal injury Congenital aplastic anaemia Gastrointestinal carcinoma Dermatitis Colitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

    Recruiting

    3 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Croatia Romania Slovakia Spain Sweden

  • Study of hypertonic saline solution and mannitol to improve recovery in patients with traumatic brain injury and high risk of intracranial hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride
    France

  • Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Ivosidenib
    Germany

  • Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • 2-Amino-9-((2R,4R,5R)-4-Hydroxy-5-(Hydroxymethyl) Tetrahydrofuran-2-Yl)-1,4,5,9-Tetrahydro-6H-Purine-6-Thione
    • Vinorelbine
    • Gemcitabine
    Hungary Poland Portugal Romania Spain

  • Study of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Hungary Poland

  • Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Carboplatin
    France Greece Italy Poland Romania
Previous Page
1 … 138 139 140 141 142 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!